Search results for "immune cell therapy"

Immuncell-LC Demonstrates Potential in Preventing Liver Cancer Recurrence Following Organ Transplant

Immuncell-LC Demonstrates Potential in Preventing Liver Cancer Recurrence Following Organ Transplant

A new study suggests that Immuncell-LC, an autologous immune cell therapy, may effectively curb cancer recurrence in liver transplant recipients—a...
CAR-T Without Extracting Patient Cells? J&J Makes $785 Million Bet on In Vivo Therapy

CAR-T Without Extracting Patient Cells? J&J Makes $785 Million Bet on In Vivo Therapy

Johnson & Johnson (J&J) is investing more than $785 million (approximately 1.11 trillion won) in next-generation "in vivo CAR-T" technology designed...
The “Stem Cell Injection” My Dermatologist Recommended — Is It Actually Stem Cell Therapy?

The “Stem Cell Injection” My Dermatologist Recommended — Is It Actually Stem Cell Therapy?

A, who has entered her mid-40s this year, has been feeling increasingly depressed when standing in front of the mirror...
Seoul St. Mary’s Hospital Wins 8 of 30 Awards at ICBMT 2026, Claiming Top Honors for Second Consecutive Year

Seoul St. Mary’s Hospital Wins 8 of 30 Awards at ICBMT 2026, Claiming Top Honors for Second Consecutive Year

The Catholic University of Korea’s Seoul St. Mary’s Hospital announced on the 20th that faculty members at its...
FDA Clears Trial for Next-Gen CAR-T Therapy That Creates Cancer-Fighting Cells Inside Patients

FDA Clears Trial for Next-Gen CAR-T Therapy That Creates Cancer-Fighting Cells Inside Patients

CAR-T therapy for blood cancers conventionally involves removing a patient’s immune cells, modifying them in a...
Seoul St. Mary’s Researchers Win Science Award for Study on HLA Antibodies in Kidney Transplants

Seoul St. Mary’s Researchers Win Science Award for Study on HLA Antibodies in Kidney Transplants

For patients awaiting kidney transplantation, elevated levels of antibodies against donor tissues pose a formidable...
GC Cell Administers Experimental CAR-NK Therapy at Seoul National University Hospital Following MFDS Approval

GC Cell Administers Experimental CAR-NK Therapy at Seoul National University Hospital Following MFDS Approval

GC Cell announced on Sept. 18 that South Korea’s Ministry of Food and Drug Safety has approved the compassionate use of...
Celltrion Files Phase 4 IND with FDA to Support 240 mg High-Dose Zymfentra Regimen in US

Celltrion Files Phase 4 IND with FDA to Support 240 mg High-Dose Zymfentra Regimen in US

Celltrion has submitted an Investigational New Drug application to the U.S. Food and Drug Administration for a Phase 4...
Can SVF Injections Delay Knee Replacement? Two-Year Tracking Shows 99% Avoided Surgery

Can SVF Injections Delay Knee Replacement? Two-Year Tracking Shows 99% Avoided Surgery

As populations age, the treatment paradigm for degenerative knee osteoarthritis is shifting from early artificial joint...
South Korea’s First Homegrown CAR-T, Rimqarto, Moves Closer to Coverage with 67% Complete Response Rate

South Korea’s First Homegrown CAR-T, Rimqarto, Moves Closer to Coverage with 67% Complete Response Rate

Curocell announced on Sept. 4 that its chimeric antigen receptor T-cell (CAR-T) therapy Rimqarto (generic name:...